# KP Pharmaceutical Technology – FDA Inspection, Nov 9, 2017

Source: https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/ed200eb9-bfc3-4a44-bc83-0809093ee866
Source feed: FDA_Inspections

> FDA inspection 1031466 of KP Pharmaceutical Technology, November 09, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1031466
- Company Name: KP Pharmaceutical Technology
- Inspection Date: 2017-11-09
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: New Drug Evaluation
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1307874 - 2026-02-13
- [FDA Inspection 1234088 - 2024-03-21](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/9de68d27-53a1-437c-bd52-951561889b31)
- [FDA Inspection 1196557 - 2023-02-03](https://www.keypedia.com/records/fda_inspections/kp-pharmaceutical-technology/5548ae02-ff10-4eff-8460-ac8c20cfecd8)
- FDA Inspection 940349 - 2015-05-21
- FDA Inspection 814448 - 2012-12-17

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/robert-m-barbosa/41672e72-4ddd-4093-8069-6e49f0c8a873)

Company: https://www.keypedia.com/companies/kp-pharmaceutical-technology/acd7d203-2bd2-4702-a902-83c45f57890f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c